Cibc World Market Inc. Lantheus Holdings, Inc. Transaction History

Cibc World Market Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	SELL	$61.42 - $86.29 $1.62 Million - $2.28 Million	-26,396 Reduced 23.1%	87,890 $6.18 Million
Q2 2022 Aug 10, 2022	BUY	$55.54 - $72.65 $2.45 Million - $3.21 Million	44,137 Added 62.92%	114,286 $7.55 Million
Q1 2022 May 12, 2022	BUY	$24.28 - $56.64 $1.7 Million - $3.97 Million	70,149 New	70,149 $3.88 Million
Q3 2019 Nov 13, 2019	SELL	$21.01 - $28.94 $2.1 Million - $2.9 Million	-100,157 Closed	0 $0
Q2 2019 Aug 08, 2019	SELL	$23.33 - $28.3 $18,384 - $22,300	-788 Reduced 0.78%	100,157 $2.83 Million
Q1 2019 May 09, 2019	BUY	$14.93 - $25.1 $1.51 Million - $2.53 Million	100,945 New	100,945 $2.47 Million

538

68.4M

679K

423K

Ticker LNTH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 68,741,904
Market Cap $6.7B
Description
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...

Get notified when there are updates to the investment portfolio of Cibc World Market Inc., based on Form 13F filings with the SEC.

Stay updated on Cibc World Market Inc. with notifications on news.